KCC Referral
Management System
Shared Care
Guidelines
Care Home
Resources
Local Resource
Packs
Chronic Pain
in Cornwall
Diabetes Resources
Respiratory Resources
Flu Resource Pack
Patient Group Direction (PGD)
Palliative Care Resources
Search   
        Click to View ALL BNF
 >>  >> 
   (Click to View Drug List)


Cost
Packs
Items
Other - Cost: £627,284,910.54 Trimbow (Beclometasone / Formoterol / Glycopyrronium MDI) - Cost: £7,640,561.00 Empagliflozin (Jardiance) - Cost: £9,180,638.84 Dapagliflozin (Forxiga) - Cost: £10,106,471.61 Edoxaban (Lixiana) - Cost: £10,215,430.75 FreeStyle Libre 2 Sensor  - Cost: £10,470,110.00 Beclometasone / Formoterol MDI (Fostair) - Cost: £16,498,070.80 Rivaroxaban (Xarelto) - Cost: £20,000,452.50 Apixaban (Eliquis) - Cost: £35,469,046.10
Formulary Notes (BNF Chapter)
Formulary Notes (BNF Section)
NICE Guidance (2)
Other Links (0)
Important Local Documents (2)
Notes for: Gastro-intestinal system
Last edited [13/08/2021 10:27:34]

Cornwall Joint Formulary Recommended Choices     (...Top)
Displaying 4 Drugs

Key:
First Line Drugs First Line Drugs
Second Line Drugs Second Line Drugs
Specialist Initiated Drugs Specialist Initiated Drugs
Hospital Only Drugs Hospital Only Drugs
Discouraged Discouraged
No comment available No comment available
Antibiotics Antibiotics

NameTariffBNF Sub Paragraph
Lubiprostone (Amitiza)
24 mcg caps Pack of 28
£29.68PCT FORMULARY STATUS: Second Line Drugs [Notes:] Lubiprostone course of treatment for constipation is 2 weeks. See NICE guidance for advice on when it may be considered. 5HT4-receptor agonistsView BNF Article on 'Lubiprostone 'View SPC on 'Lubiprostone 'View PIL on 'Lubiprostone '
Lubiprostone course of treatment for constipation is 2 weeks. See NICE guidance for advice on when it may be considered.
Linaclotide (Constella)
290 microgram caps Pack of 28
£37.56PCT FORMULARY STATUS: Specialist Initiated Drugs [Notes:] If patients have not experienced improvement in their symptoms after 4 weeks of treatment, the patient should be re-examined and the benefit and risks of continuing treatment reconsidered. 5HT4-receptor agonistsView BNF Article on 'Linaclotide'View SPC on 'Linaclotide'View PIL on 'Linaclotide'
If patients have not experienced improvement in their symptoms after 4 weeks of treatment, the patient should be re-examined and the benefit and risks of continuing treatment reconsidered.
Prucalopride (Resolor)
1 mg tab Pack of 28
£38.69PCT FORMULARY STATUS: Specialist Initiated Drugs 5HT4-receptor agonistsView BNF Article on 'Prucalopride'View SPC on 'Prucalopride'View PIL on 'Prucalopride'
Prucalopride (Resolor)
2 mg tab Pack of 28
£59.52PCT FORMULARY STATUS: Specialist Initiated Drugs 5HT4-receptor agonistsView BNF Article on 'Prucalopride'View SPC on 'Prucalopride'View PIL on 'Prucalopride'

 
© Kernow Clinical Commissioning Group 2022 - All Rights Reserved
The Sedgemoor Centre, Priory Road, St Austell, Cornwall, PL25 5AS